AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer ...Middle East

HIGHLIGHTS Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic cancer FOLFIRINOX is the most widely used treatment for pancreatic cancer patients in the US, Canada and most European countries This...

Read More Details
Finally We wish PressBee provided you with enough information of ( AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer )

Also on site :

• 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
• Sandra Oh Makes a Bold Statement About Whether She’ll Return to 'Grey’s Anatomy'
• Scott Miller Passes Away